Omega‐3 LC‐PUFA Supply and Neurological Outcomes in Children With Phenylketonuria (PKU)
Authors:
- 1 March 2009
- journal article
- review article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 48 (S1) , S2-7
Abstract
Children with phenylketonuria (PKU) follow a diet with very low intakes of natural protein, which is devoid of food sources of the omega‐3 docosahexaenoic acid (DHA). A resulting DHA depletion has been demonstrated in PKU children and may account for detectable subtle neurological deficits that are not explained by variation in plasma phenylalanine concentrations. We supplemented 36 children with PKU ages 1 to 11 years for 3 months with encapsulated fish oil providing a daily dose of 15 mg DHA/kg body weight. DHA supplementation resulted in significantly faster visual evoked potential latencies, indicating more rapid central nervous system information processing. In addition, DHA significantly improved outcomes in a test of motor function and coordination. No changes over time were seen in age‐matched healthy controls. Because the PKU children had a good supply of the omega‐3 precursor alpha‐linolenic acid, these observations lead us to conclude that endogenous conversion of alpha‐linolenic acid is not sufficient to provide adequate amounts of DHA that support optimal function, and hence DHA appears to be a conditional essential substrate for children with PKU. Because early treated PKU children are healthy, with normal fatty acid turnover, these data may indicate a need to supply some DHA to children in general. Further studies are ongoing aiming at establishing quantitative DHA requirements in children.Keywords
This publication has 41 references indexed in Scilit:
- Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsNature Reviews Immunology, 2008
- Very Low n–3 Long-Chain Polyunsaturated Fatty Acid Status in Austrian Vegetarians and VegansAnnals of Nutrition and Metabolism, 2008
- Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplementsApplied Physiology, Nutrition, and Metabolism, 2007
- Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipidsHuman Molecular Genetics, 2006
- Asbj rn F lling and the Discovery of PhenylketonuriaJournal of the History of the Neurosciences, 2003
- Long chain polyunsaturated fatty acids (LC‐PUFA) and perinatal developmentActa Paediatrica, 2001
- The Structural Basis of PhenylketonuriaMolecular Genetics and Metabolism, 1999
- Effects of a Low Birthweight Infant Formula Containing Human Milk Levels of Docosahexaenoic and Arachidonic AcidsJournal of Pediatric Gastroenterology and Nutrition, 1995
- Molecular basis of phenylketonuria and related hyperphenylalaninemias: Mutations and polymorphisms in the human phenylalanine hydroxylase geneHuman Mutation, 1992
- Reduced plasma C-20 and C-22 polyunsaturated fatty acids in children with phenylketonuria during dietary interventionThe Journal of Pediatrics, 1991